Build a diversified supplier base for fill-finish services, primary packaging and single-use technologies As the key suppliers in the industry start to prioritise larger GLP-1 contracts, you might need to expand and diversify your supplier portfolio to hedge risk, while keeping a focus on preferred partners that have consistently demonstrated high performance
Similar content being viewed by others Introduction Aging is characterized by the gradual loss of physiological function over time
This intranasal delivery method can enhance the overall efficiency and bioavailability of peptide therapy while potentially reducing the risk of systemic side effects
The long-term cardiovascular safety and efficacy of GLP-1 receptor agonists in high-risk cardiovascular populations: a systematic review and meta-analysis
Pocai A, Carrington PE, Adams JR, et al
3.7 Determination of plasma TMA levels in C57Bl/6-Fmo3 em1smoc mice Using the same method as for urine samples, TMA levels were also measured in plasma samples collected from the same experiment performed on C57Bl/6-Fmo3 em1smoc mice